Daewoong Pharmaceutical Co., Ltd (Korean: 대웅제약) is a Seoul, South Korea-based bioengineering company operating as a subsidiary of Daewoong Co., Ltd., a global health care group. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products in South Korea, including prescription and over-the-counter healthcare products.

Takara Bio Inc., develops, manufactures, and distributes a wide range of life science reagents and kits under the Takara®, Clontech®, and Cellartis® brands. Key products include SMART® cDNA synthesis kits for a variety of samples and applications, including NGS; high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes); Cellartis stem cells and stem cell reagents; RT enzymes and SMART library construction kits; the innovative In-Fusion® cloning system; Guide-it™ gene editing tools; Tet-based inducible gene expression systems; and Living Colors® fluorescent proteins. These and other products support applications including NGS; gene discovery, regulation, and function studies; protein expression and purification; RNAi, gene editing, and stem cell studies; and plant and food research

Sankyo Co., Ltd. engages in the manufacture and sale of pachinko and pachislot machines. It operates through the following segments: Pachinko Machines Business, Pachislot Machines Business, Ball Bearing Supply Systems Business, and Others. The Pachinko Machines Business segment produces and sells pachinko machines, machine gauges and its related parts. The Pachislot Machines Business segment markets pachislot machines and related parts. The Ball Bearing Supply Systems segment sells pachinko and pachislot ball feeders, card system equipment, and parlor-related equipment. The Others segment comprises of mobile content service, real estate, golf club operations, and sells general molding products. The company was established on April 12, 1966 and is headquartered in Tokyo, Japan.

Meiji Seika Pharma Co., Ltd. engages in the business of manufacture and distribution of pharmaceutical products. It also engages in the animal health business. The company was founded on October 9, 1916 and is headquartered in Tokyo, Japan.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Suzhou Martech New Material Co., Ltd., established on 2013-04-12, Business scope includes licensed business scope:General business scope:New material science research service;Technology development of new materials,consult,comminicate,transfer,Promotion service.

Dong-A Pharmaceutical Co., Ltd., a subsidiary of Dong-A Socio Holdings Co., Ltd., is a company headquartered in Seoul, the South Korea, that manufactures drug products.

Part of Kitasato University, The Kitasato Institute is a company headquartered in Tokyo, Japan, that operates a research institution.

SSP Co., Ltd. engages in the manufacture and sale of pharmaceuticals, quasi-drugs and cosmetics. The company was founded in 1765 and is headquartered in Tokyo, Japan.

Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP

Takara Shuzo Co. Ltd. manufactures and markets alcoholic beverages. Its products include alcoholic beverages, raw alcohol, health drinks, and seasonings. The company was founded in 1925 and is headquartered in Kyoto, Japan.

Manufactures, marketes and imports, exports pharmaceutical drugs

Sanko is a manufacturer and seller of press products, mechatronics products, and plastic products. Their product and technology categories include press products, plastic products, and mechanism development design proposals. Their equipment lists such as press product mass production equipment, mass production equipment for plastic products, and mold manufacturing equipment.

Nihon Nohyaku Co., Ltd. engages in the manufacture of agrochemical and pharmaceutical products. It operates through the following segments: Agrochemical, Chemical Products (except agrochemical), and Others. The Agrochemical segment produces and sells insecticides, fungicides, herbicides, pesticides, and other agrochemicals. The Chemical Products segment manufactures and distributes wood chemicals, water treatment agents, agrochemical materials, and pharmaceutical products. The Others segment deals with landscaping and greening construction, real estate leasing, logistics services, and pesticide residue analysis. The company was founded on November 17, 1928 and is headquartered in Tokyo, Japan.

Beijing Jingwei Yankang Pharmaceutical Research Institute Co., Ltd., established on 2001-08-09, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Import and export;Technology Import and Export;Agent import and export;Medical Research and Experimental Development.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Xinjiang Garlic Research Institute (Co., Ltd.), established on 2020-01-06, Business scope includes agricultural scientific research and experimental development,Medical Research and Experimental Development,Biotechnology Extension Services,Agriculture, forestry, animal husbandry and fishery technology extension services,Technology intermediary service,Conference and Exhibition Services,Nutrition and Health Consulting Services,the medical,Medical Consulting Services,Quality inspection technical service,Sales:food,cosmetic,Medicine and Medical Devices,feed,Agricultural and Livestock Products,veterinary medicine.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhongshan Wanhan Pharmaceutical Co., Ltd., established on 2013-08-29, Business scope includes pharmaceutical production;Pharmaceutical business;drug development;Production,Sales:Class I medical device;second,Three types of medical device manufacturers;second,Three types of medical device operating enterprises;Research and development of medical devices and related technical consulting services;food production;food circulation;research and development:Healthy food;research and development,production and sales:cosmetic,Chemical raw materials,Daily chemical products,specialty chemicals;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval)(The above business scope involves the import and export of goods,Technology Import and Export);Production and sales of disinfection products;disposable mask,cotton mask,dust mask,sun mask,protective suit,Goggle production and sales.(The above business scope does not include the processing of Chinese herbal medicines and the production of secret prescription products of Chinese patent medicines,Free of Hazardous Chemicals)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Anacor Pharmaceuticals is a biopharmaceutical company that engages in developing small-molecule therapeutics from its boron chemistry platform. It focuses on developing topical applications of its compounds to treat fungal, bacterial, and inflammatory diseases. The company’s primary product candidate, AN2690, is a novel topical antifungal for the treatment of toenail onychomycosis, a fungal infection of the nail and nail bed. It is also developing AN2728, an anti-inflammatory product candidate for the treatment of psoriasis; AN0128, a product candidate that has antibiotic and anti-inflammatory properties; and AN2718, which is in preclinical development for the topical treatment of vaginal candidiasis and tineapedis.